Terug
Dagbereik
€ 384,75
€ 431,80
52-Weeksbereik
€ 324,00
€ 431,80
Volume
1
50D / 200D Gem.
€ 346,00
/
€ 346,00
Vorige Slotkoers
€ 384,75
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 21,4 | 0,3 |
| P/B | 2,9 | 2,9 |
| ROE % | 13,9 | 3,7 |
| Net Margin % | 10,3 | 3,8 |
| Rev Growth 5Y % | 8,3 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,00
€ 0,00 – € 0,00
|
1,9 B | 0 |
| FY2029 |
€ 24,09
€ 23,75 – € 24,70
|
1,8 B | 1 |
| FY2028 |
€ 24,69
€ 24,35 – € 25,32
|
1,7 B | 1 |
Belangrijkste Punten
Revenue grew 8,31% annually over 5 years — modest growth
ROE of 13,91% — decent returns on equity
Debt/Equity of 0,26 — conservative balance sheet
Generating 103,37M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,53%
Capital efficient — spends only 6,30% of revenue on capex
Groei
Revenue Growth (5Y)
8,31%
Revenue (1Y)4,78%
Earnings (1Y)3,81%
FCF Growth (3Y)15,42%
Kwaliteit
Return on Equity
13,91%
ROIC11,52%
Net Margin10,30%
Op. Margin14,89%
Veiligheid
Debt / Equity
0,26
Current Ratio1,53
Interest Coverage25,29
Waardering
P/E Ratio
21,37
P/B Ratio2,87
EV/EBITDA15,57
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,78% | Revenue Growth (3Y) | 8,36% |
| Earnings Growth (1Y) | 3,81% | Earnings Growth (3Y) | 11,51% |
| Revenue Growth (5Y) | 8,31% | Earnings Growth (5Y) | 7,45% |
| Profitability | |||
| Revenue (TTM) | 1,46B | Net Income (TTM) | 150,83M |
| ROE | 13,91% | ROA | 7,88% |
| Gross Margin | 35,36% | Operating Margin | 14,89% |
| Net Margin | 10,30% | Free Cash Flow (TTM) | 103,37M |
| ROIC | 11,52% | FCF Growth (3Y) | 15,42% |
| Safety | |||
| Debt / Equity | 0,26 | Current Ratio | 1,53 |
| Interest Coverage | 25,29 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 21,37 | P/B Ratio | 2,87 |
| P/S Ratio | 2,20 | PEG Ratio | 4,51 |
| EV/EBITDA | 15,57 | Dividend Yield | 0,00% |
| Market Cap | 3,22B | Enterprise Value | 3,40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,46B | 1,40B | 1,25B | 1,22B | 1,06B |
| Net Income | 150,83M | 145,29M | 121,30M | 121,97M | 113,16M |
| EPS (Diluted) | 17,98 | 17,34 | 14,38 | 14,43 | 13,40 |
| Gross Profit | 517,74M | 937,60M | 809,60M | 794,99M | 712,85M |
| Operating Income | 218,07M | 227,50M | 184,88M | 179,52M | 167,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,91B | 1,85B | 1,46B | 1,33B | 1,20B |
| Total Liabilities | 788,89M | 805,12M | 545,81M | 494,53M | 476,36M |
| Shareholders' Equity | 1,12B | 1,04B | 900,30M | 839,33M | 724,94M |
| Total Debt | 295,15M | 307,01M | 120,11M | 90,40M | 94,47M |
| Cash & Equivalents | 122,45M | 149,63M | 175,91M | 177,38M | 172,79M |
| Current Assets | 791,59M | 844,12M | 771,48M | 723,53M | 624,67M |
| Current Liabilities | 516,12M | 464,56M | 399,05M | 390,59M | 370,75M |